BQ-3020 TFA

• Description :

  BQ-3020 (TFA) is a selective ETB receptor agonist that inhibits [125I] et-1 binding to the ETB receptor in the cerebellum with a 0.2nm IC50, causing vasoconstriction.

• Stability :

  ≥ 2 years

• Purity :

  >98% (HPLC)

• Weight :

  2120.35

• Molecular Formula :

  C98H141F3N20O27S

• Notes :

  Research use only, not for human use.

• Receptor :

  Other Targets